Characteristics | N0 | % |
---|---|---|
Age (yr) | ||
 Mean ± SD* (range) | 56 ± 11 (36–82) |  |
Gender | ||
 Male | 18 | 67 |
 Female | 9 | 33 |
Histopathology (WHOa classification) | ||
 B1 | 1 | 4 |
 B2 | 7 | 26 |
 B3 | 7 | 26 |
 Thymic carcinoma | 12 | 44 |
Stage at presentation (Masaoka-Koga) | ||
 III | 3 | 11 |
 IV A | 5 | 19 |
 IV B | 19 | 70 |
Platinum-based regimen | ||
 Yes | 23 | 85 |
 No | 4 | 15 |
Prior chemotherapy | ||
 Prior therapy for advanced TETsb | 6 | 22 |
 Prior adjuvant/neoadjuvant therapy | 5 | 19 |
 No prior therapy | 16 | 59 |
Prior surgical resection of primary tumor | ||
 Yes | 11 | 41 |
 No | 16 | 59 |
Prior radiotherapy | ||
 Yes | 5 | 19 |
 No | 22 | 81 |